We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
BioMarin Pharmaceuticals
BMRN
$11.6B
| $15.4M | 0.03% |
180,911
-9,378
| -5% | -$892K |
|
527
Sonoco
SON
$5.58B
| $15.4M | 0.03% |
289,101
+80,971
| +39% | +$4.44M |
|
528
Zions Bancorporation
ZION
$10.3B
| $15.3M | 0.03% |
374,509
+1,295
| +0.3% | +$60.4K |
|
529
Annaly Capital Management
NLY
$17.2B
| $15.2M | 0.03% |
387,971
+16,255
| +4% | +$650K |
|
|
SPLK
530
DELISTED
Splunk Inc
SPLK
| $15.1M | 0.03% |
144,028
-5,640
| -4% | -$571K |
|
|
IPG
531
DELISTED
Interpublic Group of Companies
IPG
| $15M | 0.03% |
728,682
+35,165
| +5% | +$803K |
|
532
Jones Lang LaSalle
JLL
$16.8B
| $15M | 0.03% |
118,287
+31,488
| +36% | +$4.26M |
|
533
Avery Dennison
AVY
$13.2B
| $15M | 0.03% |
166,561
-4,614
| -3% | -$434K |
|
534
Teradyne
TER
$57.3B
| $14.9M | 0.03% |
475,219
+121,841
| +34% | +$4.13M |
|
535
Western Union
WU
$2.04B
| $14.9M | 0.03% |
870,596
-18,718
| -2% | -$340K |
|
536
DaVita
DVA
$15B
| $14.8M | 0.03% |
287,693
-1,117
| -0.4% | -$71.5K |
|
|
PRAH
537
DELISTED
PRA Health Sciences, Inc.
PRAH
| $14.7M | 0.03% |
159,729
+45,356
| +40% | +$4.59M |
|
538
Old Republic International
ORI
$10.6B
| $14.6M | 0.03% |
709,598
+234,136
| +49% | +$5.02M |
|
|
SBNY
539
DELISTED
Signature Bank
SBNY
| $14.5M | 0.03% |
141,381
+40,371
| +40% | +$4.54M |
|
540
EPR Properties
EPR
$4.69B
| $14.5M | 0.03% |
225,862
+66,936
| +42% | +$4.61M |
|
541
iShares Russell 1000 ETF
IWB
$49B
| $14.4M | 0.03% |
103,686
+15,551
| +18% | +$2.33M |
|
542
Huntington Ingalls Industries
HII
$12.8B
| $14.3M | 0.03% |
75,405
-4,144
| -5% | -$902K |
|
|
DNKN
543
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $14.2M | 0.03% |
221,682
+54,638
| +33% | +$3.89M |
|
544
SL Green Realty
SLG
$3.85B
| $14.2M | 0.03% |
185,403
-1,018
| -0.5% | -$90.1K |
|
545
Mohawk Industries
MHK
$8.11B
| $14.1M | 0.03% |
120,927
+4,342
| +4% | +$579K |
|
546
Wolfspeed
WOLF
$1.26B
| $14.1M | 0.03% |
330,605
+133,494
| +68% | +$5.41M |
|
|
MASI
547
DELISTED
Masimo
MASI
| $14.1M | 0.03% |
131,500
+36,927
| +39% | +$4.12M |
|
548
Watsco Inc
WSO
$13.1B
| $14M | 0.03% |
100,422
+19,990
| +25% | +$3.05M |
|
549
Hanover Insurance
THG
$8.09B
| $14M | 0.03% |
119,573
+36,962
| +45% | +$4.15M |
|
550
HF Sinclair
DINO
$15.8B
| $13.9M | 0.03% |
272,748
-1,333
| -0.5% | -$81.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.